( out of 16 reviews )
-
Specialties
Board Certification
American Board of Pediatrics (Pediatrics)American Board of Pediatrics (Sub: Pediatric Endocrinology)National Board of Medical ExaminersPatient Rating
5.0 /5( out of 16 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
-
Board Certification and Academic Information
Academic Departments Pediatrics -Associate Professor (Clinical)
Academic Divisions Diabetes & Endocrinology
Board Certification American Board of Pediatrics (Pediatrics)American Board of Pediatrics (Sub: Pediatric Endocrinology)National Board of Medical ExaminersEducation history
Fellowship Pediatrics Endocrinology - Department of Pediatrics, Division of Endocrinology, Cincinnati Children's Hospital Medical Center Chief Fellow Fellowship Pediatric Endocrinology - Cincinnati Children's Hospital Medical Center Fellow Residency Pediatrics - Monroe Carell Jr. Children's Hospital at Vanderbilt Resident Professional Medical Medicine - University of Cincinnati College of Medicine M.D. Undergraduate Psychology & Pre-Medical Studies - University of Notre Dame B.A. Selected Publications
Journal Article
- Ospelt E, Hardison H, Rioles N, Noor N, Weinstock RS, Cossen K, Mathias P, Smego A, Mathioudakis N, Ebekozien O, T1D Exchange Quality Improvement Collaborative (2023). Understanding Providers' Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study. Clin Diabetes, 42(1), 17-26. ()
- Miyazaki B, Ebekozien O, Rompicherla S, Ohmer A, Guttman-Bauman I, Mucci A, Guarneri A, Raman V, Smego A, Dickinson JK (2023). Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019. Diabetes Spectr, 36(4), 398-402. ()
- Lawson S, Redel JM, Smego A, Gulla M, Schoettker PJ, Jolly M, Mostajabi F, Hornung L (2020). Assessment of a Day Hospital Management Program for Children With Type 1 Diabetes. JAMA Netw Open, 3(3), e200347. ()
- Smego A, Lawson S, Courter JD, Warden D, Corathers S (2018). Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes. Hosp Pediatr, 8(5), 288-292. ()
- Smego A, Woo JG, Klein J, Suh C, Bansal D, Bliss S, Daniels SR, Bolling C, Crimmins NA (2017). High Body Mass Index in Infancy May Predict Severe Obesity in Early Childhood. J Pediatr, 183, 87-93.e1. ()
- Smego AR, Backeljauw P, Gutmark-Little I (2016). Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy. J Clin Endocrinol Metab, 101(5), 2084-8. ()
Abstract
- Canter R, Raman V, Sund S, Sirstins J, Edwards A, Counter M, Whitaker B, Wadhwa T, Couldwell M, Smego A (2024). Increasing Scheduling of Adult Diabetes Care Prior to Graduation from Pediatric Diabetes Care for Patients with Type 1 Diabetes. [Abstract]. 16(S1), 32.
- Coletti M, Keene J, Smego A, Young M, Ostrander B (2024). Endocrine, Ophthalmic and Developmental Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Presented at International Newborn Brain Conference Feb 2024 by lead author. [Abstract]. 17(3), S293-S295.
- Demeterco-Berggren, C, Jacobsen, L, Guttman-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Choudhary, A, Wong, J, Ebekozien, O (2024). Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among centers participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Poster Presentation at the 84th ADA Scientific Sessions. June 2024. [Abstract]. 73(S1), 1293-P.
- Smego A, Asfour F, Sirstins J, Loizos C, Counter M, Whitaker B, Bjerregaard S, Wadhwa T, Gubler L, Raman V (2023). Increasing Pump Therapy Adoption in Patients with Type 1 Diabetes [Abstract]. 15(S1), 28-29.
- Coletti M, Keene J, Smego A, Young M, Ostrander B (2023). Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Poster presentation at Child Neurology Society in Fall 2023. [Abstract]. 94(S31), S70.
- Jelley H, Mistry S, Meder M, Smego A, Raman V (2023). Health Inequities in the Use of Diabetes Technology Among Racial/Ethnic Minority Pediatric Patients with Type 1 Diabetes. Presented Pediatric Endocrine Society 2023. [Abstract]. 96(S3), 122-128.
- Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E (2023). Possible Insulin Allergy Presenting with Anaphylaxis. Presented at Pediatric Endocrine Society 2023. [Abstract]. 96(S3), 122-128.
- Ospelt E, Hardison H, Rioles N, Noor N, Crossen S, Smego A, Aleppo G, Friedman J, Eng D, Sullivan C, Majidi S, Lorincz I, Ebekozien O (2023). Provider Perceptions of Barriers and Benefits to Type 1 Diabetes Autoantibody Testing Among Patients and Relatives. Poster Presentation at the 83rd ADA Scientific Sessions. June 2023. [Abstract]. 72(S1), 1290.
- Morales Moreno J, Smego A, Stipleman C (2023). Risk-based Quality Improvement for Type 2 Diabetes Screening in Primary Care. American Pediatric Association, Region 9 & 10 Meeting. Monterey, CA. [Abstract].
- Meder M, Jelley H, Gallenberger M, Murray M, Zhang Y, Li H, Smego A (2022). Use of Basal-Bolus Subcutaneous Insulin in the Initial Management of Mild to Moderate Diabetic Ketoacidosis is Safe in Type 1 Diabetes. [Abstract]. 95(Suppl 1), 76-77.
- Meder M, Jelley H, Smego A, Raman V, Raleigh Z (2022). Addison's Disease Presenting with Recurrent Pericardial Effusion and Cardiac Tamponade. [Abstract]. 95(Suppl 1), 17-18.
- Jelley H, Meder M, Murray M, Raman V, Raleigh Z, Foster C, Smego A, Kocolas I, Al-Hamad D (2021). Infantile hypophosphatasia as a cause of severe hypotonia and hypercalcemia. [Abstract]. 94(Suppl 2), 14-15.
Video/Film/CD/Web/Podcast
- Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego A (2021). Diagnosis and Treatment of Pediatric Type 1 Diabetes. Care Process Model. Intermountain Healthcare. [Web]. Available: https://intermountainhealthcare.org/ckr-ext/Dcmnt?ncid=520451313.
- Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego A (2021). Management and Treatment of Pediatric Type 2 Diabetes. Care Process Model. Intermountain Healthcare. [Web]. Available: https://intermountainhealthcare.org/ckr-ext/Dcmnt?ncid=529163870.
-
News & Podcasts